MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR

Abstract Background Acute myeloid leukemia (AML) with the t(8;21)(q22;q22) chromosomal translocation is among the most common subtypes of AML and produces the AML1-ETO (RUNX1-ETO, RUNX1-RUNX1T1) oncogenic fusion gene. AML1-ETO functions as an aberrant transcription factor which plays a key role in b...

Full description

Bibliographic Details
Main Authors: Daniel T. Johnson, Amanda G. Davis, Jie-Hua Zhou, Edward D. Ball, Dong-Er Zhang
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40164-021-00204-7
id doaj-97aa952932a64c95aa998f264c9dbc5e
record_format Article
spelling doaj-97aa952932a64c95aa998f264c9dbc5e2021-02-07T12:51:59ZengBMCExperimental Hematology & Oncology2162-36192021-02-0110111210.1186/s40164-021-00204-7MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTRDaniel T. Johnson0Amanda G. Davis1Jie-Hua Zhou2Edward D. Ball3Dong-Er Zhang4Moores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaMoores Cancer Center, University of CaliforniaAbstract Background Acute myeloid leukemia (AML) with the t(8;21)(q22;q22) chromosomal translocation is among the most common subtypes of AML and produces the AML1-ETO (RUNX1-ETO, RUNX1-RUNX1T1) oncogenic fusion gene. AML1-ETO functions as an aberrant transcription factor which plays a key role in blocking normal hematopoiesis. Thus, the expression of AML1-ETO is critical to t(8;21) AML leukemogenesis and maintenance. Post-transcriptional regulation of gene expression is often mediated through interactions between trans-factors and cis-elements within transcript 3′-untranslated regions (UTR). AML1-ETO uses the 3′UTR of the ETO gene, which is not normally expressed in hematopoietic cells. Therefore, the mechanisms regulating AML1-ETO expression via the 3’UTR are attractive therapeutic targets. Methods We used RNA-sequencing of t(8;21) patients and cell lines to examine the 3′UTR isoforms used by AML1-ETO transcripts. Using luciferase assay approaches, we test the relative contribution of 3′UTR cis elements to AML1-ETO expression. We further use let-7b microRNA mimics and anti-let-7b sponges for functional studies of t(8;21) AML cell lines. Results In this study, we examine the regulation of AML1-ETO via the 3’UTR. We demonstrate that AML1-ETO transcripts primarily use a 3.7 kb isoform of the ETO 3′UTR in both t(8;21) patients and cell lines. We identify a negative regulatory element within the AML1-ETO 3′UTR. We further demonstrate that the let-7b microRNA directly represses AML1-ETO through this site. Finally, we find that let-7b inhibits the proliferation of t(8;21) AML cell lines, rescues expression of AML1-ETO target genes, and promotes differentiation. Conclusions AML1-ETO is post-transcriptionally regulated by let-7b, which contributes to the leukemic phenotype of t(8;21) AML and may be important for t(8;21) leukemogenesis and maintenance.https://doi.org/10.1186/s40164-021-00204-7AML1-ETO (RUNX1-RUNX1T1)let-7miRNAt(8;21) acute myeloid leukemia
collection DOAJ
language English
format Article
sources DOAJ
author Daniel T. Johnson
Amanda G. Davis
Jie-Hua Zhou
Edward D. Ball
Dong-Er Zhang
spellingShingle Daniel T. Johnson
Amanda G. Davis
Jie-Hua Zhou
Edward D. Ball
Dong-Er Zhang
MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
Experimental Hematology & Oncology
AML1-ETO (RUNX1-RUNX1T1)
let-7
miRNA
t(8;21) acute myeloid leukemia
author_facet Daniel T. Johnson
Amanda G. Davis
Jie-Hua Zhou
Edward D. Ball
Dong-Er Zhang
author_sort Daniel T. Johnson
title MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
title_short MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
title_full MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
title_fullStr MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
title_full_unstemmed MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
title_sort microrna let-7b downregulates aml1-eto oncogene expression in t(8;21) aml by targeting its 3′utr
publisher BMC
series Experimental Hematology & Oncology
issn 2162-3619
publishDate 2021-02-01
description Abstract Background Acute myeloid leukemia (AML) with the t(8;21)(q22;q22) chromosomal translocation is among the most common subtypes of AML and produces the AML1-ETO (RUNX1-ETO, RUNX1-RUNX1T1) oncogenic fusion gene. AML1-ETO functions as an aberrant transcription factor which plays a key role in blocking normal hematopoiesis. Thus, the expression of AML1-ETO is critical to t(8;21) AML leukemogenesis and maintenance. Post-transcriptional regulation of gene expression is often mediated through interactions between trans-factors and cis-elements within transcript 3′-untranslated regions (UTR). AML1-ETO uses the 3′UTR of the ETO gene, which is not normally expressed in hematopoietic cells. Therefore, the mechanisms regulating AML1-ETO expression via the 3’UTR are attractive therapeutic targets. Methods We used RNA-sequencing of t(8;21) patients and cell lines to examine the 3′UTR isoforms used by AML1-ETO transcripts. Using luciferase assay approaches, we test the relative contribution of 3′UTR cis elements to AML1-ETO expression. We further use let-7b microRNA mimics and anti-let-7b sponges for functional studies of t(8;21) AML cell lines. Results In this study, we examine the regulation of AML1-ETO via the 3’UTR. We demonstrate that AML1-ETO transcripts primarily use a 3.7 kb isoform of the ETO 3′UTR in both t(8;21) patients and cell lines. We identify a negative regulatory element within the AML1-ETO 3′UTR. We further demonstrate that the let-7b microRNA directly represses AML1-ETO through this site. Finally, we find that let-7b inhibits the proliferation of t(8;21) AML cell lines, rescues expression of AML1-ETO target genes, and promotes differentiation. Conclusions AML1-ETO is post-transcriptionally regulated by let-7b, which contributes to the leukemic phenotype of t(8;21) AML and may be important for t(8;21) leukemogenesis and maintenance.
topic AML1-ETO (RUNX1-RUNX1T1)
let-7
miRNA
t(8;21) acute myeloid leukemia
url https://doi.org/10.1186/s40164-021-00204-7
work_keys_str_mv AT danieltjohnson micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr
AT amandagdavis micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr
AT jiehuazhou micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr
AT edwarddball micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr
AT dongerzhang micrornalet7bdownregulatesaml1etooncogeneexpressionint821amlbytargetingits3utr
_version_ 1724280655428190208